Aurobindo Pharma jumps nearly 7% after cancelling ₹420-cr Cronus Pharma deal
Aurobindo Pharma announced on August 12 that it had entered into definitive agreements to subscribe to fresh equity shares in Hyderabad-based Cronus.
By hindustantimes.com | Written by Meenakshi Ray, New Delhi
UPDATED ON AUG 23, 2021…